Erik Hans MANTING

Person

Leiden, NL

People

Patents Grantslast 30 patents

Information Patent Grant
Ex vivo use of modified cells of leukemic origin for enhancing the...
- Patent number 12,091,681
- Issue date Sep 17, 2024
- MENDUS B.V.
- Erik Hans Manting
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination product for use in tumor vaccination
- Patent number 11,071,778
- Issue date Jul 27, 2021
- DCPrime B.V.
- Erik Hans Manting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of tumor vaccination
- Patent number 11,052,144
- Issue date Jul 6, 2021
- DCPrime B.V.
- Erik Hans Manting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF LEUKEMIA-DERIVED CELLS FOR ENHANCING NATURAL KILLER (NK) CEL...
- Publication number 20240002800
- Publication date Jan 4, 2024
- Mendus B.V.
- Alex Karlsson-Parra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED CELLS OF LEUKEMIC ORIGIN AND A PD-L1 ANTIBODY FOR ENHANCIN...
- Publication number 20230355760
- Publication date Nov 9, 2023
- Mendus B.V.
- Erik Hans Manting
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF VACCINATION AND USE OF CD47 BLOCKADE
- Publication number 20220305100
- Publication date Sep 29, 2022
- DCPRIME B.V.
- Erik Hans Manting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TUMOR VACCINATION
- Publication number 20220249639
- Publication date Aug 11, 2022
- DCPRIME B.V.
- Erik Hans Manting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF TUMOR-INDEPENDENT ANTIGENS IN IMMUNOTHERAPIES
- Publication number 20220168407
- Publication date Jun 2, 2022
- DCPRIME B.V.
- Erik Hans MANTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCT FOR USE IN TUMOR VACCINATION
- Publication number 20220023406
- Publication date Jan 27, 2022
- DCPRIME B.V.
- Erik Hans MANTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF LEUKEMIA-DERIVED CELLS IN OVARIAN CANCER VACCINES
- Publication number 20220023405
- Publication date Jan 27, 2022
- DCPRIME B.V.
- Erik Hans Manting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TUMOR VACCINATION
- Publication number 20210401961
- Publication date Dec 30, 2021
- DCPRIME B.V.
- Erik Hans MANTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IN VIVO USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN FOR ENHANCING THE...
- Publication number 20210322471
- Publication date Oct 21, 2021
- DCPRIME B.V.
- Erik Hans Manting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EX VIVO USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN FOR ENHANCING THE...
- Publication number 20210324332
- Publication date Oct 21, 2021
- DCPRIME B.V.
- Erik Hans Manting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCT FOR USE IN TUMOR VACCINATION
- Publication number 20200397883
- Publication date Dec 24, 2020
- DCPRIME B.V.
- Erik Hans MANTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TUMOR VACCINATION
- Publication number 20200390876
- Publication date Dec 17, 2020
- DCPRIME B.V.
- Erik Hans MANTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Erik Hans MANTING

Person

Patents Grantslast 30 patents

Ex vivo use of modified cells of leukemic origin for enhancing the...

Combination product for use in tumor vaccination

Methods of tumor vaccination

Patents Applicationslast 30 patents

USE OF LEUKEMIA-DERIVED CELLS FOR ENHANCING NATURAL KILLER (NK) CEL...

MODIFIED CELLS OF LEUKEMIC ORIGIN AND A PD-L1 ANTIBODY FOR ENHANCIN...

METHODS OF VACCINATION AND USE OF CD47 BLOCKADE

METHODS OF TUMOR VACCINATION

USE OF TUMOR-INDEPENDENT ANTIGENS IN IMMUNOTHERAPIES

COMBINATION PRODUCT FOR USE IN TUMOR VACCINATION

USE OF LEUKEMIA-DERIVED CELLS IN OVARIAN CANCER VACCINES

METHODS OF TUMOR VACCINATION

IN VIVO USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN FOR ENHANCING THE...

EX VIVO USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN FOR ENHANCING THE...

COMBINATION PRODUCT FOR USE IN TUMOR VACCINATION

METHODS OF TUMOR VACCINATION